The availability of cheaper alternatives, even with their inherent risks, has expanded access to millions, fundamentally reshaping the market's competitive dynamics and forcing a reevaluation of long-term investment theses in Novo Nordisk and Eli Lilly
Dive Brief: A pill from Structure Therapeutics helped people in a Phase 2 trial in obesity lose as much as 15% of their body weight over 44 weeks, results that suggest the drug, aleniglipron, could be competitive with rival medications from Eli Lilly and Novo Nordisk
This powerful antioxidant may help inhibit melanin production, leading to a more even and radiant complexion
Beatrice Vallone (Sapienza University of Rome, Italy) and Dr
If you're looking to maintain muscle and emphasize fat loss, keeping your protein intake high can be important too